1. HBW Insight
  2. >>Geography
  3. >>Asia
  4. >>China

Herbalife Under SEC Scrutiny On Regulatory Compliance In China

 
• By Eileen Francis

Herbalife is the focus of a Securities and Exchange Commission investigation into anti-corruption compliance in the firm’s China business, the company reported in a Jan. 20 regulatory filing. An analyst covering the stock believes the investigation will have little impact on growth.

No stranger to regulatory scrutiny, Herbalife Ltd. again is under US regulators' spotlight as the Securities and Exchange Commission investigates the nutrition and weight loss supplement direct seller’s anti-corruption compliance in China.

Herbalife announced the probe in a Jan. 20 SEC filing that gave few details about the investigation

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from China

Haleon Completes Deal To Grow Stake In China JV

 
• By Tom Gallen

Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.

Self-Care ‘Essential’ To Universal Health Coverage, Stress Asia Pacific Health Agencies

 
• By David Ridley

APAC health agencies such as WHO and Thailand's FDA are on board with the self-care agenda, and see it as crucial to achieving universal health coverage.

Haleon Talks Up China Strength As Investment Grows

 
• By Tom Gallen

Haleon highlighted consistent market share gains in China as it reported third-quarter results.

Haleon Strengthens Control Of China JV, Agrees Option To Buy

 
• By Tom Gallen

Joint venture business which markets Haleon's OTC drug brands in China will soon be 88% owned by the UK-based firm.

More from Asia